ADGEF(Gefitinib)
Therapeutic class: Kinase Inhibitors
Indication: First-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) , Treatment of patients with metastatic, squamous NSCLC progressing after platinum-based chemotherapy
20 mg & 30 mg & 40 mg tablets
20 mg:-
A bottle of 10 tablets30 mg:-
A bottle of 10 tablets40 mg:-
A bottle of 10 tablets- 20°C to 25°C (68°F to 77°F), Shelf Life: 2 Years
- As directed by physician
